+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Corynebacterium accolens new species a gram positive rod exhibiting satellitism from clinical material



Corynebacterium accolens new species a gram positive rod exhibiting satellitism from clinical material



Systematic & Applied Microbiology 14(1): 46-51



Seventy-eight bacterial strains isolated from various clinical materials were examined for their basic characteristics, i.e. satellite growth in the vicinity of Staphylococcus aureus colonies. The growth appears to depend on utilisation of organic or inorganic sulphur, but not on factors X and V. The bacterium is an aerobic Gram-positive rod of typical coryneform shape with metachromatic granules. On the basis of various physiological and genomic characteristics this group of bacteria is described as Corynebacterium accolens sp. nov. The type strain is CNCTC Th 1/57.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 007165415

Download citation: RISBibTeXText


Related references

Corynebacterium accolens sp. nov., a Gram-Positive Rod Exhibiting Satellitism, from Clinical Material. Systematic and Applied Microbiology 14(1): 46-51, 1991

Corynebacterium mucofaciens sp nov, An unusual Corynebacterium species isolated from human clinical material. Abstracts of the General Meeting of the American Society for Microbiology 97(0): 141, 1997

In vitro action of gentamicin on gram-negative and gram-positive bacteria isolated from clinical material. Hospital 76(3): 903-907, 1969

Evaluation of the RapID CB Plus system for identification of Corynebacterium species and other gram-positive rods. Journal of Clinical Microbiology 36(2): 543-547, 1998

Premarket evaluation prototype panel for identification of corynebacterium species and gram positive rods. Abstracts of the General Meeting of the American Society for Microbiology 97(0): 200, 1997

Streptomycin, a substance exhibiting antibiotic activity against gram-positive and gram-negative bacteria. Proc Soc Exp Biol And Med 55(1): 66-69, 1944

The Classic: Streptomycin, a Substance Exhibiting Antibiotic Activity against Gram-Positive and Gram-Negative Bacteria. Clinical Orthopaedics and Related Research® &na;(437): 3-6, 2005

Streptomycin, a substance exhibiting antibiotic activity against gram-positive and gram-negative bacteria. 1944. Clinical Orthopaedics and Related Research 2005(437): 3-6, 2005

Corynebacterium accolens-associated pelvic osteomyelitis. Journal of Clinical Microbiology 48(2): 654-655, 2010

Classification of a bacterial isolate, from pozol, exhibiting antimicrobial activity against several gram-positive and gram-negative bacteria, yeasts, and molds. Journal of Food Protection 63(8): 1123-1132, 2000

Significance of the characteristic chemical pattern of gram positive and gram negative bacterial cell walls corynebacterium cervicis. Nature (London) 215(5107): 1286-1287, 1967

In vitro activities of daptomycin, vancomycin, quinupristin- dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolates. Antimicrobial Agents and ChemoTherapy 47(1): 337-341, 2002

In Vitro Activities of Daptomycin, Vancomycin, Quinupristin- Dalfopristin, Linezolid, and Five Other Antimicrobials against 307 Gram-Positive Anaerobic and 31 Corynebacterium Clinical Isolates. Antimicrobial Agents and ChemoTherapy 47(4): 1486-1486, 2003

Corynebacterium accolens isolated from breast abscess: possible association with granulomatous mastitis. Journal of Clinical Microbiology 45(5): 1666-1668, 2007

In vitro activities of the new semisynthetic glycopeptide telavancin (TD-6424), vancomycin, daptomycin, linezolid, and four comparator agents against anaerobic gram-positive species and Corynebacterium spp. Antimicrobial Agents and ChemoTherapy 48(6): 2149-2152, 2004